BABA vs LEVI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

LEVI presents a compelling growth-at-a-reasonable-price (GARP) opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.30) that sits comfortably below its growth-based intrinsic value of $40.12. While the Graham Number suggests a lower defensive floor of $13.25, the company's exceptional ROE of 25.41% and strong earnings growth (32.6% YoY) justify a premium. Despite bearish insider sentiment and a weak technical trend, the fundamental trajectory is supported by consistent earnings beats and a P/E ratio significantly lower than the sector average.